NeoGenomics, Inc. (NEO) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Neogenomics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.151 -- 00:00:05.273 Good afternoon and welcome to the NeoGenomics second quarter 2026 financial results 00:00:05.273 -- 00:00:09.915 call. At this time, all participants are in a listen-only mode. 00:00:09.915 -- 00:00:13.176 Please be advised that today's conference is being recorded. 00:00:13.176 -- 00:00:18.338 I will now turn the call over to Abhishek Jain, Chief Financial 00:00:18.338 -- 00:00:20.338 Officer. 00:00:21.659 -- 00:00:27.041 Before we begin, I would like to introduce Andrew Brackman, who recently joined NeoGenomics 00:00:27.041 -- 00:00:30.483 as our new Vice President of Investor Relations. 00:00:30.483 -- 00:00:35.648 Andrew spent nearly a decade in sell-side equity research covering the diagnostic sector. 00:00:35.648 -- 00:00:40.652 He also covered neogenomics directly, giving him a deep understanding of both the company 00:00:40.652 -- 00:00:45.576 and its competitive landscape. Beyond his analytical depth, Andrew is known for building 00:00:45.576 -- 00:00:49.459 genuine, long-term relationships with the people he works with. 00:00:49.459 -- 00:00:54.464 We're excited to have Andrew on board to lead and shape our investor relations strategy 00:00:54.464 -- 00:00:58.942 and deepen our relationships across the investor and analyst community. 00:00:58.942 -- 00:01:01.844 Now let me turn the call over to Andrew to get us started. 00:01:01.844 -- 00:01:02.904 Andrew? 00:01:02.904 -- 00:01:05.426 Thank you, Abhishek, and good afternoon, everyone. 00:01:05.426 -- 00:01:08.867 I am excited to be joining Neogenomics in this role. 00:01:08.867 -- 00:01:12.629 Having covered the stock for the last eight years during my time at William Blair, I 00:01:12.629 -- 00:01:16.692 have been inspired by the team's ability to leverage its well-earne...